Pressure BioSciences Inc. PBIO Archives - Page 2 of 22

ThursdayJun 30, 2022 1:07 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation in Upcoming Webinar Focused on Revolutionizing Development of Plant-Based Food Products

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide food and beverage, biotherapeutics, and personal wellness industries, will e participating in a June 30 webinar sponsored by FORCE Family Office. Titled “Revolutionizing the Development of Plant-Based Food Products,” the real-time, interactive event will provide information about PBIO’s three pressure-based technology platforms, with an emphasis on the company’s Ultra Shear Technology(TM) (“UST”) platform. The company is inviting investors, analysis and advisors to attend the presentation, which will include a question-and-answer segment. The webinar is scheduled…

WednesdayJun 29, 2022 11:47 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters ‘Pivotal’ Agreement for Nanoemulsified CBD Spray for Oral Use

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agrochem and food/beverage industries, is partnering with Safer Medical of Montana (“SMM”) in an exclusive distribution agreement. SMM is a seasoned distributor of wellness products with a focus on veterans. The new partnership entails an agreement for production, distribution, commercial roll-out and finances for a novel, effectively water-soluble, nanoemulsified CBD spray for oral use. According to the announcement, SMM's roll-out and distribution plan anticipates revenues of $3 million or more over the…

TuesdayJun 14, 2022 3:10 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Potential of UST(TM) as ‘Essential Tool in Future Beverage Development’

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and beverage, biotherapeutics and other industries, today announced a pivotal peer-reviewed scientific publication. The piece highlights the use of PBI’s patented Ultra Shear Technology(TM) (“UST(TM)”) platform in the production of protein-enriched milk containing a novel emulsified plant-protein suspension. J.J. Janahar, et al., from The Ohio State University College of Food, Agricultural and Environmental Sciences (“CFAES”), in a study published in the high impact journal Food Hydrocolloids, reported that UST successfully created stable suspensions of…

WednesdayJun 01, 2022 2:45 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses UST(TM) Platform, Early Access Program on Stock Day Podcast

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences markets and other industries. The company was featured in a recent episode of The Stock Day Podcast, where its CEO Richard T. Schumacher joined Stock Day host Sever Copley to discuss PBI’s Ultra Shear Technology(TM)(“UST(TM)”) for the processing of nanoemulsions. The company has seven issued UST patents to date, including two in the U.S., with many more expected to follow. “The oil in these emulsions typically contains the valuable active ingredients,…

FridayMay 20, 2022 10:31 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases First-Quarter 2022 Financial Report, Corporate Update

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, is reporting its financial results for Q1 2022, the period ended March 31, 2022; the company also released a business update provided guidance for the remainder of the year. Key numbers from the report include total revenue for the quarter totaling $480,000, down 14% from $560,000 for Q1 2021; instrument sales of $465,000, compared to $553,800 for Q1 2021; and consumable sales for the quarter reached $40,000,…

WednesdayMay 04, 2022 1:59 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters First UST Early Access Manufacturing Agreement

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, has signed its inaugural nanoemulsions development and manufacturing agreement under its recently released Ultra Shear Technology(TM) (“UST”) early-access program. The agreement, signed with Safer Medical of Montana (“SMM”), covers formulation, pilot batches and commercial production for a CBD topical spray designed to reduce pain. According to the announcement, all products discussed in the contract will include high-quality nanoemulsions of oils in water produced by using PBI's revolutionary…

TuesdayMay 03, 2022 12:35 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate at Upcoming Planet MicroCap Showcase

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, will be presenting at the 2022 Planet Microcap Showcase. The three-day event, scheduled for May 3–5, 2022, will be held in Las Vegas and will feature more than 80 top public and private companies. Pressure BioSciences president and CEO Richard T. Schumacher will be presenting at 11:30 a.m. PDT on May 4. During his presentation, Schumacher will discuss the company’s achievements regarding the nanoemulsification of CBD and…

WednesdayApr 27, 2022 12:34 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Early Access Program for Use of Its Revolutionary UST(TM) Platform

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biotechnology and other industries. The company today announced the initiation of an Early Access Program (effective July 1, 2022) for the use of its revolutionary Ultra Shear Technology(TM) (“UST(TM)”) platform for the processing of oil-based active ingredients into highly stable, water-soluble, long-term stable nanoemulsions. “We have announced our plans to have commercial toll-production UST-processing capacity operational on the East and West coasts of the USA by Q4 2022,” said John B. Hollister, director of…

WednesdayApr 20, 2022 12:00 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured on Stock Day Podcast

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences and other industries, was featured in a recent episode of The Stock Day Podcast. The company’s president and CEO Richard T. Schumacher joined Stock Day host Everett Jolly to discuss PBI’s revolutionary UST Platform and planned 2022 uplisting. “UST is an amazing technology as you and your listeners know. It is a very innovative technology with enormous potential in a myriad of industries. I suppose the easiest way to describe the power…

TuesdayApr 19, 2022 3:35 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at Sequire Cannabis & Psychedelics Conference

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty services to the worldwide biopharmaceuticals and other industries, today announced its participation as a presenter at the Sequire Cannabis & Psychedelics Investor Conference. The virtual event, taking place on April 20, 2022, will feature over 30 top public companies in the cannabis and psychedelics space. PBI’s president and CEO Richard T. Schumacher is scheduled to present, beginning at 10:30 a.m. ET, and will expand on the company's recent achievements in the nanoemulsification of CBD and other cannabinoids, as well…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO